These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23685297)

  • 21. [Endovascular radiofrequency denervation of renal arteries as an innovation method of treatment of refractory arterial hypertension. First experience in Russia].
    Danilov NM; Matchin IuG; Chazova IE
    Angiol Sosud Khir; 2012; 18(1):51-4. PubMed ID: 22836328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catheter-based renal denervation for treatment of resistant hypertension.
    Vase H; Mathiassen ON; Kaltoft A; Pedersen EB; Christensen KL; Buus NH; Lederballe O; Lassen JF; Bøtker HE; Thuesen L
    Dan Med J; 2012 Jun; 59(6):A4439. PubMed ID: 22677237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel non-vascular system to treat resistant hypertension.
    Heuser RR; Mhatre AU; Buelna TJ; Berci WL; Hubbard BS
    EuroIntervention; 2013 May; 9(1):135-9. PubMed ID: 23685301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation.
    Schmieder RE; Ott C; Schmid A; Friedrich S; Kistner I; Ditting T; Veelken R; Uder M; Toennes SW
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Renal artery denervation for treating refractory hypertension].
    Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
    Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal denervation for the treatment of hypertension: Making a new start, getting it right.
    Weber MA; Kirtane A; Mauri L; Townsend RR; Kandzari DE; Leon MB
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):855-63. PubMed ID: 26097069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension.
    Ezzahti M; Moelker A; Friesema EC; van der Linde NA; Krestin GP; van den Meiracker AH
    J Hypertens; 2014 Jan; 32(1):135-41. PubMed ID: 24131897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.
    Kario K; Bhatt DL; Brar S; Cohen SA; Fahy M; Bakris GL
    Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraprocedural reduction of the veno-arterial norepinephrine gradient correlates with blood pressure response after renal denervation.
    Tiroch K; Sause A; Szymanski J; Nover I; Leischik R; Mann JF; Vorpahl M; Seyfarth M
    EuroIntervention; 2015 Nov; 11(7):824-34. PubMed ID: 26603990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension.
    Weber MA; Kirtane AJ; Weir MR; Radhakrishnan J; Das T; Berk M; Mendelsohn F; Bouchard A; Larrain G; Haase M; Diaz-Cartelle J; Leon MB
    JACC Cardiovasc Interv; 2020 Feb; 13(4):461-470. PubMed ID: 32081240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transradial renal denervation for the treatment of resistant hypertension.
    Dong H; Jiang X; Liang T; Zou Y; Guan T; Peng M; Song L; Zhang H; Wu H; Xu B; Yang Y; Gao R
    J Invasive Cardiol; 2014 Jul; 26(7):322-7. PubMed ID: 24993989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system.
    Tsioufis CP; Papademetriou V; Dimitriadis KS; Kasiakogias A; Tsiachris D; Worthley MI; Sinhal AR; Chew DP; Meredith IT; Malaiapan Y; Thomopoulos C; Kallikazaros I; Tousoulis D; Worthley SG
    Int J Cardiol; 2015 Dec; 201():345-50. PubMed ID: 26301677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcatheter Alcohol-Mediated Perivascular Renal Denervation With the Peregrine System: First-in-Human Experience.
    Fischell TA; Ebner A; Gallo S; Ikeno F; Minarsch L; Vega F; Haratani N; Ghazarossian VE
    JACC Cardiovasc Interv; 2016 Mar; 9(6):589-98. PubMed ID: 27013159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does renal artery supply indicate treatment success of renal denervation?
    Schmid A; Ditting T; Sobotka PA; Veelken R; Schmieder RE; Uder M; Ott C
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):987-91. PubMed ID: 23771326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system.
    Kaiser L; Beister T; Wiese A; von Wedel J; Meincke F; Kreidel F; Busjahn A; Kuck KH; Bergmann MW
    EuroIntervention; 2014 May; 10(1):157-65. PubMed ID: 24472799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of endovascular ultrasound renal denervation in resistant hypertension: 12-month results from the ACHIEVE study.
    Daemen J; Mahfoud F; Kuck KH; Andersson B; Böhm M; Graf T; Sievert H; Kahlert P; Iyer M; Zeller T
    J Hypertens; 2019 Sep; 37(9):1906-1912. PubMed ID: 31045964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications.
    Kandzari DE; Kario K; Mahfoud F; Cohen SA; Pilcher G; Pocock S; Townsend R; Weber MA; Böhm M
    Am Heart J; 2016 Jan; 171(1):82-91. PubMed ID: 26699604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
    Khan NA; Herman RJ; Quinn RR; Rabkin SW; Ravani P; Tobe SW; Feldman RD; Wijeysundera HC; Padwal RS;
    Can J Cardiol; 2014 Jan; 30(1):16-21. PubMed ID: 24269056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First report of transradial renal denervation with the dedicated radiofrequency Iberis™ catheter.
    Honton B; Pathak A; Sauguet A; Fajadet J
    EuroIntervention; 2014; 9(12):1385-8. PubMed ID: 24161437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial.
    Azizi M; Sapoval M; Gosse P; Monge M; Bobrie G; Delsart P; Midulla M; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Trillaud H; Pereira H; Plouin PF; Chatellier G;
    Lancet; 2015 May; 385(9981):1957-65. PubMed ID: 25631070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.